Home LiteratureArticle Details
PMID: 10933713 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.

Journal of virology ·Vol. 74 ·No. 17 ·2000-09-00 ·Pages 8038-47

Suárez T, Gallaher WR, Agirre A, Goñi FM, Nieva JL

Abstract

We have identified a region within the ectodomain of the fusogenic human immunodeficiency virus type 1 (HIV-1) gp41, different from the fusion peptide, that interacts strongly with membranes. This conserved sequence, which immediately precedes the transmembrane anchor, is not highly hydrophobic according to the Kyte-Doolittle hydropathy prediction algorithm, yet it shows a high tendency to partition into the membrane interface, as revealed by the Wimley-White interfacial hydrophobicity scale. We have investigated here the membrane effects induced by NH(2)-DKWASLWNWFNITNWLWYIK-CONH(2) (HIV(c)), the membrane interface-partitioning region at the C terminus of the gp41 ectodomain, in comparison to those caused by NH(2)-AVGIGALFLGFLGAAGSTMGARS-CONH(2) (HIV(n)), the fusion peptide at the N terminus of the subunit. Both HIV(c) and HIV(n) were seen to induce membrane fusion and permeabilization, although lower doses of HIV(c) were required for comparable effects to be detected. Experiments in which equimolar mixtures of HIV(c) and HIV(n) were used indicated that both peptides may act in a cooperative way. Peptide-membrane and peptide-peptide interactions underlying those effects were further confirmed by analyzing the changes in fluorescence of peptide Trp residues. Replacement of the first three Trp residues by Ala, known to render a defective gp41 phenotype unable to mediate both cell-cell fusion and virus entry, also abrogated the HIV(c) ability to induce membrane fusion or form complexes with HIV(n) but not its ability to associate with vesicles. Hydropathy analysis indicated that the presence of two membrane-partitioning stretches separated by a collapsible intervening sequence is a common structural motif among other viral envelope proteins. Moreover, sequences with membrane surface-residing residues preceding the transmembrane anchor appeared to be a common feature in viral fusion proteins of several virus families. According to our experimental results, such a feature might be related to their fusogenic function.

MeSH Terms
Amino Acid Motifs Amino Acid Sequence Amino Acid Substitution Cell Membrane/physiology Fluorometry HIV Envelope Protein gp41/chemistry,physiology HIV-1/chemistry,pathogenicity,physiology Humans Membrane Fusion/physiology Molecular Sequence Data Mutagenesis, Site-Directed Protein Structure, Tertiary Sequence Alignment
Chemicals
HIV Envelope Protein gp41
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Suárez T
Unidad de Biofísica (CSIC-UPV/EHU) and Departamento de Bioquímica, Universidad del País Vasco, 48080 Bilbao, Spain.
Gallaher W R
Agirre A
Goñi F M
Nieva J L
References (46)
46 references, click to expand
  1. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus.
    Cell. 1987 Jul 31;50(3):327-8 PMID: 3496970
  2. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential.
    Biochim Biophys Acta. 1985 Jan 10;812(1):55-65 PMID: 23008845
  3. A general model for the transmembrane proteins of HIV and other retroviruses.
    AIDS Res Hum Retroviruses. 1989 Aug;5(4):431-40 PMID: 2788443
  4. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.
    Proc Natl Acad Sci U S A. 1990 Jun;87(12):4650-4 PMID: 2191297
  5. Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41.
    Biochemistry. 1990 Aug 28;29(34):7917-22 PMID: 2261447
  6. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.
    Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):70-4 PMID: 1729720
  7. Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function.
    AIDS Res Hum Retroviruses. 1992 Jan;8(1):9-18 PMID: 1736943
  8. The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation.
    Biochim Biophys Acta. 1992 Aug 25;1139(4):257-74 PMID: 1355364
  9. Membrane fusion.
    Science. 1992 Nov 6;258(5084):917-24 PMID: 1439803
  10. Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes.
    Biochim Biophys Acta. 1993 Jan 18;1145(1):124-33 PMID: 8422404
  11. Non-random distribution of amino acids in the transmembrane segments of human type I single span membrane proteins.
    J Mol Biol. 1993 Feb 5;229(3):602-8 PMID: 8433362
  12. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage.
    Biochemistry. 1994 Mar 22;33(11):3201-9 PMID: 8136355
  13. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
    Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9770-4 PMID: 7937889
  14. Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion.
    J Virol. 1995 Jun;69(6):3308-14 PMID: 7745678
  15. Characterization and modeling of membrane proteins using sequence analysis.
    Curr Opin Struct Biol. 1995 Aug;5(4):491-500 PMID: 8528765
  16. Interbilayer lipid mixing induced by the human immunodeficiency virus type-1 fusion peptide on large unilamellar vesicles: the nature of the nonlamellar intermediates.
    Chem Phys Lipids. 1999 Dec;103(1-2):11-20 PMID: 10701076
  17. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.
    Nature. 1981 Jan 29;289(5796):366-73 PMID: 7464906
  18. Use of resonance energy transfer to monitor membrane fusion.
    Biochemistry. 1981 Jul 7;20(14):4093-9 PMID: 7284312
  19. A simple method for displaying the hydropathic character of a protein.
    J Mol Biol. 1982 May 5;157(1):105-32 PMID: 7108955
  20. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7 PMID: 6096719
  21. H+- and Ca2+-induced fusion and destabilization of liposomes.
    Biochemistry. 1985 Jun 18;24(13):3099-106 PMID: 4027232
  22. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses.
    Cell. 1996 May 17;85(4):477-8 PMID: 8653783
  23. Experimentally determined hydrophobicity scale for proteins at membrane interfaces.
    Nat Struct Biol. 1996 Oct;3(10):842-8 PMID: 8836100
  24. Virus-cell and cell-cell fusion.
    Annu Rev Cell Dev Biol. 1996;12:627-61 PMID: 8970739
  25. Core structure of gp41 from the HIV envelope glycoprotein.
    Cell. 1997 Apr 18;89(2):263-73 PMID: 9108481
  26. Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study.
    J Biol Chem. 1997 May 23;272(21):13496-505 PMID: 9153194
  27. Atomic structure of the ectodomain from HIV-1 gp41.
    Nature. 1997 May 22;387(6631):426-30 PMID: 9163431
  28. Structural study of the relationship between the rate of membrane fusion and the ability of the fusion peptide of influenza virus to perturb bilayers.
    Biochemistry. 1997 Jun 24;36(25):7644-51 PMID: 9201905
  29. Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry.
    Virology. 1997 Sep 1;235(2):179-90 PMID: 9281497
  30. Enveloped viruses: a common mode of membrane fusion?.
    Curr Biol. 1997 Sep 1;7(9):R565-9 PMID: 9285698
  31. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
    Biophys J. 1997 Oct;73(4):1977-86 PMID: 9336193
  32. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.
    J Cell Biol. 1998 Jan 26;140(2):315-23 PMID: 9442107
  33. Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus.
    J Virol. 1998 Mar;72(3):1775-81 PMID: 9499027
  34. Capture of an early fusion-active conformation of HIV-1 gp41.
    Nat Struct Biol. 1998 Apr;5(4):276-9 PMID: 9546217
  35. HIV entry and its inhibition.
    Cell. 1998 May 29;93(5):681-4 PMID: 9630213
  36. Protein folding in membranes: determining energetics of peptide-bilayer interactions.
    Methods Enzymol. 1998;295:62-87 PMID: 9750214
  37. The preference of tryptophan for membrane interfaces.
    Biochemistry. 1998 Oct 20;37(42):14713-8 PMID: 9778346
  38. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.
    Nat Med. 1998 Nov;4(11):1302-7 PMID: 9809555
  39. Structural biology of HIV.
    J Mol Biol. 1999 Jan 8;285(1):1-32 PMID: 9878383
  40. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.
    J Virol. 1999 Mar;73(3):2469-80 PMID: 9971832
  41. Structural basis for paramyxovirus-mediated membrane fusion.
    Mol Cell. 1999 Mar;3(3):309-19 PMID: 10198633
  42. Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion.
    J Virol. 1999 Jul;73(7):6089-92 PMID: 10364363
  43. Membrane protein folding and stability: physical principles.
    Annu Rev Biophys Biomol Struct. 1999;28:319-65 PMID: 10410805
  44. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.
    Nat Struct Biol. 1999 Oct;6(10):953-60 PMID: 10504731
  45. Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket.
    Cell. 1999 Oct 1;99(1):103-15 PMID: 10520998
  46. Identification of the fusion peptide of primate immunodeficiency viruses.
    Science. 1989 May 12;244(4905):694-7 PMID: 2541505
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2000-09-00
Pages
8038-47
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC112336
Subset
IM
Grants
NIAID NIH HHS · 1F32AI08549 · United States
NIDCR NIH HHS · 1R01DE10862 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com